Abbott (ABT) Tops Q3 EPS by 4c, Raises Guidance

(Updated - October 18, 2023 7:35 AM EDT)

Abbott (NYSE: ABT) reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10 Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.82 billion.

GUIDANCE:

Abbott sees FY2023 EPS of $4.42-$4.46, versus the consensus of $4.18.

• Abbott narrowed its full-year 2023 EPS guidance range. Abbott projects full-year diluted EPS on a GAAP basis of $3.14 to $3.18 and projects adjusted diluted EPS of $4.42 to $4.46, which represents an increase at the midpoint of the guidance range.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Piper Sandler on Abbott Labs (ABT): 'A Name Worth Revisiting'